CALR and breast carcinoma: Since IHC confirmed the differential expression of calreticulin in breast cancer tissues, we developed an in vitro CRT-knockdown model of breast cancer using siRNA to examine the effects of CRT expression modulation on the invasive potential of MCF7 breast cancer cells.